PU.1: A crucial and versatile player in hematopoiesis and leukemia

被引:71
作者
Kastner, Philippe
Chan, Susan
机构
[1] IGBMC, F-67404 Illkirch Graffenstaden, France
[2] INSERM, F-67400 Illkirch Graffenstaden, France
[3] CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France
[4] Univ Strasbourg 1, F-67000 Strasbourg, France
关键词
Spi-1; hematopoiesis; leukemia;
D O I
10.1016/j.biocel.2007.01.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purine Rich Box-1 (PU.1)/SFFV Proviral Integration Site-1 (Spi-1) is an Ets-family transcription factor, which was first characterized as an oncogene in Friend's murine erythroleukemia, and subsequently, as a transcriptional regulator of myeloid promoters. PU.1 has since emerged as a central regulator of all hematopoietic cell lineages. PU.1 is essential for terminal myeloid cell differentiation, B and T cell development, erythropoiesis and hematopoietic stem cell maintenance. These pleiotropic functions are reflected by its complex and dynamic expression pattern during hematopoiesis. Factors regulating this complex expression are only beginning to be revealed. Interestingly, recent work has provided strong evidence that suppression of PU.1 function is critical for the leukemic transformation of myeloid cells, both in mouse and man. Thus PU.1 is a multi-faceted protein that controls numerous normal and pathogenic functions within the hematopoietic system. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 28 条
  • [1] Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage
    Anderson, MK
    Weiss, AH
    Hernandez-Hoyos, G
    Dionne, CJ
    Rothenberg, EV
    [J]. IMMUNITY, 2002, 16 (02) : 285 - 296
  • [2] Visualizing PU.1 activity during hematopoiesis
    Back, J
    Allman, D
    Chan, S
    Kastner, P
    [J]. EXPERIMENTAL HEMATOLOGY, 2005, 33 (04) : 395 - 402
  • [3] PU.1 determines the self-renewal capacity of erythroid progenitor cells
    Back, J
    Dierich, A
    Bronn, C
    Kastner, P
    Chan, S
    [J]. BLOOD, 2004, 103 (10) : 3615 - 3623
  • [4] PU.1 expression delineates heterogeneity in primary Th2 cells
    Chang, HC
    Zhang, SM
    Thieu, VT
    Slee, RB
    Bruns, HA
    Laribee, RN
    Klemsz, MJ
    Kaplan, MH
    [J]. IMMUNITY, 2005, 22 (06) : 693 - 703
  • [5] PU. 1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain
    Cook, WD
    McCaw, BJ
    Herring, C
    John, DL
    Foote, SJ
    Nutt, SL
    Adams, JM
    [J]. BLOOD, 2004, 104 (12) : 3437 - 3444
  • [6] PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
    Dakic, A
    Metcalf, D
    Di Rago, L
    Mifsud, S
    Wu, L
    Nutt, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) : 1487 - 1502
  • [7] PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors
    DeKoter, RP
    Walsh, JC
    Singh, H
    [J]. EMBO JOURNAL, 1998, 17 (15) : 4456 - 4468
  • [8] ETS transcription factors and regulation of immunity
    Gallant, Sarah
    Gilkeson, Gary
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2006, 54 (03) : 149 - 163
  • [9] Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation
    Iwasaki, H
    Somoza, C
    Shigematsu, H
    Duprez, EA
    Iwasaki-Arai, J
    Mizuno, S
    Arinobu, Y
    Geary, K
    Zhang, P
    Dayaram, T
    Fenyus, ML
    Elf, S
    Chan, S
    Kastner, P
    Huettner, CS
    Murray, R
    Tenen, DG
    Akashi, K
    [J]. BLOOD, 2005, 106 (05) : 1590 - 1600
  • [10] Transcriptional regulation of the cyclooxygenase-2 gene in macrophages by PU.1
    Joo, M
    Park, GY
    Wright, JG
    Blackwell, TS
    Atchison, ML
    Christman, JW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (08) : 6658 - 6665